Received May 8, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 2 | Z002625 | — |
patient involved has not reported any medical concerns; expired STERILE DILUENT used for administration of non-expired VARIVAX.; This spontaneous report was received from a pharmacist 06-May-2026 and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 24-Apr-2026, the patient was vaccinated with a second dose (reported as two dose series) of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX UPGRADE), (lot #Z002625, expiration date: 08-Jan-2027), dose:0.5 ml, total, (route was unspecified) for Prophylaxis. The vaccine was reconstituted with an expired dose of sterile diluent (Hollister-Stier STERILE DILUENT) (route, dose, dose number, lot #, and expiration date were unspecified) dose: 0.7 mL (0.7 mL / total reported as once) for an unknown indication for Prophylaxis (Expired product administered), on the same date. Pharmacist confirmed that the patient involved had not reported any medical concerns.
DILUENT MRK